Belhaven Biopharma | Finanzwire

Basculer en Français

10938	Companies
238839	Keywords
167680	Articles
128375	Press releases

Home
Companies
Belhaven Biopharma

BRIEF

published on 07/09/2024 at 17:05, 2 years 1 month ago

Belhaven Biopharma Study Shows Promising Results for Nasal Epinephrine Delivery

Belhaven Biopharma Nasdepi Anaphylaxis Treatment Medical Research Nasal Epinephrine
PRESS RELEASE

published on 07/09/2024 at 17:00, 2 years 1 month ago

New Canine Study From Belhaven Biopharma Supports Dry Powder Nasal Epinephrine Delivery Solution
Belhaven Biopharma presents promising results of Nasdepi Canine Study at Respiratory Drug Delivery 2024, indicating faster & effective treatment for anaphylaxis. Intranasal dry powder epinephrine offers breakthrough prospects in emergency care for severe allergies

Belhaven Biopharma Anaphylaxis Treatment Nasdepi Canine Study Dry Powder Nasal Solution Respiratory Drug Delivery 2024
PRESS RELEASE

published on 02/08/2024 at 18:30, 2 years 6 months ago

Belhaven Biopharma Announces Groundbreaking Clinical Results for Nasdepi, the Revolutionary Nasal Dry Powder Epinephrine Product
Belhaven Biopharma shares positive results from Phase 1 clinical trial of Nasdepi, a nasal dry powder epinephrine device for treating anaphylaxis. Successful investor round and Series A financing on the horizon

Phase 1 Clinical Trial Series A Financing Belhaven Biopharma Nasdepi Anaphylaxis Treatment
PRESS RELEASE

published on 11/28/2023 at 19:30, 2 years 9 months ago

Belhaven Biopharma Achieves Significant Milestones in Advancing Nasdepi - a Revolutionary Nasal Dry Powder Epinephrine Product

Accesswire

Published on 09/05/2026 at 04:05, 1 day 5 hours ago

Pelican AI Corp. Announces Proposed Share Issuances and Litigation Update
Published on 09/04/2026 at 23:30, 1 day 9 hours ago

FutureGen Industries Announces Shares for Debt Settlement
Published on 09/04/2026 at 23:00, 1 day 10 hours ago

Golden Minerals Announces Management Change and Argentine Project Update
Published on 09/04/2026 at 22:30, 1 day 10 hours ago

Panther Minerals Closes Brokered Private Placement of $3,000,000
Published on 09/04/2026 at 14:30, 1 day 18 hours ago

Additional Infant Patient to Receive Jaguar Health's Crofelemer for Compassionate Use for Treatment of Intestinal Failure (IF)

View all ACCESSWIRE

EQS Group

Published on 09/06/2026 at 06:00, 3 hours 23 minutes ago

CoolFly to Showcase Personal Flight Portfolio and NA80 Flight-Control Technology at IFA Berlin 2026
Published on 09/06/2026 at 05:15, 4 hours 9 minutes ago

Experience AI Companion in Everyday Life at Hisense IFA 2026
Published on 09/05/2026 at 22:20, 11 hours 4 minutes ago

PITAKA Marks Its Next Chapter in Berlin With "Signals in the Wind," Unveiling New iPhone 18 Accessories
Published on 09/05/2026 at 19:35, 13 hours 49 minutes ago

ToolDance Unveils X1 Smart Desktop CNC Mill at IFA 2026
Published on 09/05/2026 at 14:00, 19 hours 24 minutes ago

Global investment boom could create USD 200 billion commercial insurance opportunity amid rising accumulation risks, finds Swiss Re Institute

Les Echos

Published on 09/04/2026 at 18:57, 1 day 14 hours ago

Disclosure of transactions in own shares from September 1 to September 4, 2026
Published on 09/04/2026 at 17:45, 1 day 15 hours ago

Declaration of voting rights at the end of August 2026
Published on 09/04/2026 at 17:45, 1 day 15 hours ago

DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS
Published on 09/04/2026 at 16:00, 1 day 17 hours ago

Disclosure of Share Capital and Voting Rights Outstanding as of July 31, 2026
Published on 09/04/2026 at 16:00, 1 day 17 hours ago

Disclosure of Share Capital and Voting Rights Outstanding as of August 31, 2026

View all LES ECHOS COMFI WIRE